Details of the Drug Combinations

General Information of This Drug (ID: DMOWTRL)

Drug Name

GSK-2315698 DMOWTRL

Synonyms

GSK-2315698A; Serum amyloid P depleter (iv, amyloidosis), GlaxoSmithKline

Indication

Disease Entry	ICD 11	Status	REF
Amyloidosis	5D00	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
GSK2398852 + GSK-2315698	DCVSNIC	GSK2398852	Amyloidosis	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01777243) A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)